Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRB10 interacting GYF protein 1 (GIGYF1) is an adaptor protein belonging to the GYF family, characterized by a GYF protein interaction domain. GIGYF1 interacts with GRB10, an adaptor protein that modulates signaling downstream of the insulin and IGF-1 receptors. Through these interactions, GIGYF1 regulates receptor signaling, enhances insulin and IGF-1 receptor phosphorylation, and participates in metabolic and growth pathways. Beyond this, GIGYF1 is a translational repressor: it binds the translation initiation machinery (specifically, the eIF3 complex) and disrupts interactions necessary for efficient mRNA translation, notably repressing the production of certain transcripts such as interferon-β. GIGYF1 is broadly expressed and may play diverse roles in translational control, genome stability, and metabolic regulation. Loss-of-function mutations in GIGYF1 are associated with a range of disorders, from neurodevelopmental syndromes (including autism spectrum disorder) to metabolic dysfunction (including diabetes and altered glucose homeostasis). No approved drugs specifically target GIGYF1 at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRB10 interacting GYF protein 1 (GIGYF1).